MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202511011849 A) filed by Akums Drugs & Pharmaceuticals Limited on February 12, 2025, for Fixed Dose Combination Of Empagliflozin And Glitazones.
Inventor includes Jain Sanjeev.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention relates to fixed dose combination of Empagliflozin and Glitazones wherein glitazones is selected from Pioglitazone or Lobeglitazone or its salts. The fixed dose combination may be formulated as a tablet, capsule, or other suitable solid or liquid dosage forms. The fixed dose combination improves the glycemic goals, lowers the overall cost, reduces the ...